• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中大麻滥用与脑形态:现有证据的综述。

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

机构信息

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg-August-University, Germany.

出版信息

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):3-13. doi: 10.1007/s00406-012-0346-3. Epub 2012 Aug 21.

DOI:10.1007/s00406-012-0346-3
PMID:22907121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560946/
Abstract

Substance abuse is the most prevalent comorbid psychiatric condition associated with schizophrenia, and cannabis is the illicit drug most often abused. Apart from worsening the course of schizophrenia, frequent cannabis use especially at an early age seems to be an important risk factor for developing schizophrenia. Although a large body of neuroimaging studies gives evidence for structural alterations in many different brain regions in schizophrenia patients, there is still limited knowledge of the impact of cannabis abuse on brain structure in schizophrenia. We performed a systematic review including structural magnetic resonance imaging studies comparing high-risk and schizophrenia patients with and without cannabis abuse and found inconclusive results. While there is some evidence that chronic cannabis abuse could alter brain morphology in schizophrenia in patients continuing their cannabis consumption, there is no convincing evidence that this alteration takes place before the onset of schizophrenia when looking at first-episode patients. There is some weak evidence that cannabis abuse could affect brain structures in high-risk subjects, but replication of these studies is needed.

摘要

物质滥用是与精神分裂症相关的最常见共病精神疾病,大麻是最常被滥用的非法药物。除了使精神分裂症的病程恶化外,频繁使用大麻(尤其是在早期)似乎是导致精神分裂症的一个重要危险因素。尽管大量的神经影像学研究为精神分裂症患者许多不同脑区的结构改变提供了证据,但对于大麻滥用对精神分裂症患者大脑结构的影响仍知之甚少。我们进行了一项系统综述,纳入了比较有高风险和精神分裂症且有和无大麻滥用的患者的结构磁共振成像研究,结果尚无定论。虽然有一些证据表明,慢性大麻滥用可能会改变继续吸食大麻的精神分裂症患者的大脑形态,但在观察首发患者时,没有令人信服的证据表明这种改变发生在精神分裂症发病之前。有一些微弱的证据表明大麻滥用可能会影响高风险人群的大脑结构,但需要对这些研究进行复制。

相似文献

1
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.精神分裂症中大麻滥用与脑形态:现有证据的综述。
Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):3-13. doi: 10.1007/s00406-012-0346-3. Epub 2012 Aug 21.
2
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
3
[Cannabis and psychosis: search of a causal link through a critical and systematic review].[大麻与精神病:通过批判性系统综述探寻因果联系]
Encephale. 2009 Sep;35(4):377-85. doi: 10.1016/j.encep.2008.02.012. Epub 2008 Jul 9.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.

引用本文的文献

1
Magnetic resonance imaging-based machine learning classification of schizophrenia spectrum disorders: a meta-analysis.基于磁共振成像的精神分裂症谱系障碍机器学习分类:一项荟萃分析。
Psychiatry Clin Neurosci. 2024 Dec;78(12):732-743. doi: 10.1111/pcn.13736. Epub 2024 Sep 18.
2
Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response.大麻使用障碍与纹状体连接性在抗精神病药物治疗反应中的相互作用。
Schizophr Bull Open. 2020 Jan;1(1):sgaa014. doi: 10.1093/schizbullopen/sgaa014. Epub 2020 Mar 20.
3
Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.精神障碍合并物质使用障碍患者的神经影像学研究:研究结果总结
Front Psychiatry. 2019 Oct 23;10:702. doi: 10.3389/fpsyt.2019.00702. eCollection 2019.
4
Impact of substance use disorder on gray matter volume in schizophrenia.物质使用障碍对精神分裂症患者脑灰质体积的影响。
Psychiatry Res Neuroimaging. 2018 Oct 30;280:9-14. doi: 10.1016/j.pscychresns.2018.08.002. Epub 2018 Aug 3.
5
The adverse health effects and harms related to marijuana use: an overview review.与使用大麻相关的健康不良影响和危害:综述
CMAJ Open. 2018 Aug 16;6(3):E339-E346. doi: 10.9778/cmajo.20180023. Print 2018 Jul-Sep.
6
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.大麻使用者首发精神病患者采用大麻二酚治疗的潜力。
Schizophr Bull. 2018 Jan 13;44(1):46-53. doi: 10.1093/schbul/sbx105.
7
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.低风险大麻使用指南:证据与建议的全面更新
Am J Public Health. 2017 Aug;107(8):e1-e12. doi: 10.2105/AJPH.2017.303818. Epub 2017 Jun 23.
8
Safety and Toxicology of Cannabinoids.大麻素的安全性与毒理学
Neurotherapeutics. 2015 Oct;12(4):735-46. doi: 10.1007/s13311-015-0380-8.
9
Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.精神病临床高危青少年大脑区域体积或皮质厚度异常缺乏证据:高危青少年纵向研究结果
Schizophr Bull. 2015 Nov;41(6):1285-93. doi: 10.1093/schbul/sbv012. Epub 2015 Mar 4.
10
Reduced hippocampal volume and hypothalamus-pituitary-adrenal axis function in first episode psychosis: evidence for sex differences.首发精神病患者海马体积减小及下丘脑-垂体-肾上腺轴功能异常:性别差异证据
Neuroimage Clin. 2014 Dec 5;7:195-202. doi: 10.1016/j.nicl.2014.12.001. eCollection 2015.

本文引用的文献

1
Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders.青少年精神分裂症患者和青少年大麻使用障碍患者的顶叶脑区体积缺陷。
J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):171-80. doi: 10.1016/j.jaac.2011.11.001. Epub 2011 Dec 14.
2
A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia.一项系统的荟萃分析评估了非遗传风险因素和精神分裂症潜在前驱因素的证据。
Schizophr Res. 2011 Dec;133(1-3):133-42. doi: 10.1016/j.schres.2011.09.020. Epub 2011 Oct 13.
3
Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.大麻使用对精神分裂症家族高危人群丘脑体积的影响。
Br J Psychiatry. 2011 Nov;199(5):386-90. doi: 10.1192/bjp.bp.110.090175. Epub 2011 Sep 8.
4
Schizophrenia as a disorder of disconnectivity.精神分裂症:一种连接中断的疾病。
Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 2(Suppl 2):S150-4. doi: 10.1007/s00406-011-0242-2. Epub 2011 Aug 25.
5
Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.青少年和年轻成人的小脑灰质缺陷、大麻使用与首发精神分裂症。
Int J Neuropsychopharmacol. 2012 Apr;15(3):297-307. doi: 10.1017/S146114571100068X. Epub 2011 May 4.
6
Cerebellar white-matter changes in cannabis users with and without schizophrenia.大麻使用者合并与不合并精神分裂症患者的小脑白质改变。
Psychol Med. 2011 Nov;41(11):2349-59. doi: 10.1017/S003329171100050X. Epub 2011 Apr 5.
7
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.大麻素受体 1 基因多态性与大麻滥用对精神分裂症患者脑白质和认知功能障碍的交互作用。
Schizophr Res. 2011 May;128(1-3):66-75. doi: 10.1016/j.schres.2011.02.021. Epub 2011 Mar 21.
8
Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS).青少年起病精神分裂症患者中早期使用大麻与更大的灰质和白质变化有关。
Schizophr Res. 2011 May;128(1-3):91-7. doi: 10.1016/j.schres.2011.02.014. Epub 2011 Mar 8.
9
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.长期抗精神病药物治疗与脑容量:首发精神分裂症的纵向研究
Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.
10
Antipsychotic medications and brain volume: do we have cause for concern?抗精神病药物与脑容量:我们是否应予以关注?
Arch Gen Psychiatry. 2011 Feb;68(2):126-7. doi: 10.1001/archgenpsychiatry.2010.187.